WAVE Life Sciences (WVE)
(Real Time Quote from BATS)
$5.08 USD
+0.15 (3.04%)
Updated May 1, 2024 09:42 AM ET
3-Hold of 5 3
F Value F Growth B Momentum F VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
WVE 5.08 +0.15(3.04%)
Will WVE be a Portfolio Killer in May?
Zacks Investment Research is releasing its prediction for WVE based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for WVE
NeoGenomics (NEO) Reports Q1 Loss, Tops Revenue Estimates
Wave Life Sciences (WVE) Surges 10.9%: Is This an Indication of Further Gains?
WVE: What are Zacks experts saying now?
Zacks Private Portfolio Services
Wave Life Sciences (WVE) Soars 8.7%: Is Further Upside Left in the Stock?
Wave Life Sciences (WVE) Reports Q2 Loss, Tops Revenue Estimates
Wave Life Sciences (WVE) Reports Q1 Loss, Lags Revenue Estimates
Other News for WVE
Wave Life Sciences Announces Approval of First Clinical Trial Application for RestorAATion-2 Trial of WVE-006 in Individuals with Alpha-1 Antitrypsin Deficiency (AATD)
Wave Life announces approval of first CTA for RestorAAtion-2 trial
Analysts’ Top Healthcare Picks: AbbVie (ABBV), Wave Life Sciences (WVE)
Buy Rating Affirmed: Strategic Partnerships and Clinical Milestones Propel Wave Life Sciences’ Growth Potential
Wave Life Sciences: A Promising Buy Rating Based on Strategic GSK Collaboration and Innovative siRNA Platform